Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHEVAL trial of rivastigmine for minor visual hallucinations in Parkinson's disease
NL-OMON44866Phase 4Active, not recruiting
- Sponsor
- Vrije University Medical Center
- Start
- Nov 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Parkinson's disease (PD) comparing Rivastigmine with Placebo (2 arms). Primary endpoints: Median time to progression to major visual hallucinations without insight and Start of antipsychotic treatment. Started Nov 2013; status: active, not recruiting.
02
Drugs
rivastigmine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NL-OMON44866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44866.